Abstract
Rituximab therapy is a promising treatment for primary Sjogren's syndrome (pSS).1 ,2 So far, treatment studies performed in patients with pSS lacked the use of a uniform outcome measure to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have